Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Medicine for inhibiting Marek's disease virus replication and preventing or resisting Marek's disease

A technology for Marek's disease and virus replication, applied in antitumor drugs, antiviral agents, drug combinations, etc., can solve the problems of unreported pharmacological functions, no MDV virus replication, etc., to achieve enhanced effect, good economic value and Research significance, strong effect

Active Publication Date: 2021-06-18
JILIN UNIV
View PDF0 Cites 2 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

Its pharmacological function has not been reported so far, and so far there has not been any report about DUBs-IN-3 anti-MD or any inhibition of MDV virus replication

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Medicine for inhibiting Marek's disease virus replication and preventing or resisting Marek's disease
  • Medicine for inhibiting Marek's disease virus replication and preventing or resisting Marek's disease
  • Medicine for inhibiting Marek's disease virus replication and preventing or resisting Marek's disease

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0043] DUBs-IN-1 inhibits the enzymatic activity of UL36 encoded by MDV.

[0044] Enzyme reaction system: 2.5nM UL36 protein in 100μL reaction system, 1× reaction buffer (50mM HEPESpH7.8, 0.1mg / mL BSA, 0.5mM EDTA, 1mM DTT), add reaction fluorescent substrate Ub-AMC, 37 Incubate at °C, and measure the change in fluorescence intensity on a fluorescence spectrophotometer. The reaction system added with 5 μM DUBs-IN-1 was used as "inhibitor group", and the reaction system without DUBs-IN-1 but added with the same amount of solvent DMSO was used as "no inhibitor group". The result is as figure 1 , UL36 in the "no inhibitor group" hydrolyzed Ub-AMC normally and produced a fluorescent signal, while the activity of UL36 in the "inhibitor group" was inhibited, and the fluorescent signal did not increase. This result indicated that DUBs-IN-1 inhibited the enzymatic activity of UL36 encoded by MDV.

Embodiment 2

[0046] DUBs-IN-1 inhibits MDV replication at the level of CEF cells.

[0047] Preparation of CEF cells and infection with MDV:

[0048] 1. Take SPF chicken embryos aged 9-11 days, wipe the chicken embryos with alcohol cotton, and wipe and disinfect from the air chamber to the surrounding. Then put the chicken embryo into the ultra-clean workbench with the air cell facing up. Carefully tap the air cell with autoclaved forceps and clip off the eggshell.

[0049] 2. Use new sterile tweezers to uncover the allantoic chorion, and discard the egg shell and vitelline membrane. Hold the head of the embryo with sterilized forceps and gently transfer it to the plate.

[0050] 3. Fix the head with sterilized tweezers, cut off the head, limbs, and organs with sterilized scissors, and rinse repeatedly with sterilized PBS until colorless.

[0051] 4. Use sterilized scissors to cut the tissue pieces until there are no large particles of tissue, add 8 mL of sterilized PBS to wash, let sta...

Embodiment 3

[0068] DUBs-IN-1 inhibits the replication of MDV and the occurrence of MD at the level of chicken MD disease model.

[0069] The specific operation is: take 1-day-old SPF chickens, according to the MDV titer of 1000PFU, the way of challenge is intraperitoneal inoculation, these challenge chickens are treated with intraperitoneal injection of DUBs-IN-1 every day, and the experiment is divided into 0.001, 0.005, 0.01, 0.04, 0.1, 0.15 and 0.2, a total of 7 groups, no drug treatment, only injected with the same amount of DMSO as the control group. 10 chickens per group. 20 days after the challenge, blood was collected from the blood vessels under the wings, T lymphocytes were separated, and the quantitative analysis of the MDV gene copy number was carried out according to the number of 200,000 cells, as shown in Figure 7 . The MD incidence rate of each group chicken in 50 days after the statistical challenge, such as Figure 8 . 50 days after the challenge or when they were o...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention provides a medicine for inhibiting Marek's disease virus replication, which comprises a deubiquitinating enzyme UL36 inhibitor and a medicine for preventing or resisting Marek's disease. The deubiquitinating enzyme UL36 inhibitor DUBs-IN-1 and the derivative thereof are screened out for the first time through an enzyme activity experiment for inhibiting virus encoding, a drug toxicity experiment on a CEF cell level, a virus CPE inhibition experiment and a chicken Marek's disease model experiment, the activity of UL36 can be inhibited on an enzyme level, replication of Marek's disease viruses can be inhibited on a cell level, and the Marek's disease tumor growth and visceral hemorrhage can be inhibited on the animal level, has the advantages of extremely strong effect and small dosage, and can be widely applied to production practice of Marek's disease prevention in poultry industry as an anti-MD drug.

Description

technical field [0001] The invention relates to the application field of compounds, in particular to the application of DUBs-IN-1 and its derivatives as drugs for inhibiting the replication of Marek's disease virus and for preventing the occurrence of Marek's disease. Background technique [0002] Marek's disease (MD) is a highly contagious, highly pathogenic, lymphoproliferative viral neoplastic disease caused by chickens infected with the pathogenic serotype I type Marek's disease virus (MDV), which is spread all over the world Widely exist, my country and Egypt are countries with high incidence of this disease. Therefore, MD is an important threat to my country's poultry industry. Chicken is the most important natural host of MDV, which belongs to the cell-associated herpesviridae family, and its molecular structure and gene composition are similar to alphaherpesviruses. Unless kept under strict Specific Pathogen Free (SPF) conditions, all flocks can become infected, eve...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): A61K31/498A61P31/22A61P35/00
CPCA61K31/498A61P31/22A61P35/00A61K2300/00
Inventor 艾永兴李占军许家翠徐媛媛
Owner JILIN UNIV
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com